Zimmer Biomet Holdings EMEA — Goodwill Gross decreased by 0.2% to $1.40B in Q1 2026 compared to the prior quarter.
An increase indicates recent acquisition activity within the region, while stability suggests no new M&A activity.
Represents the total historical cost of goodwill recorded for the EMEA geographic segment before any accumulated impairm...
Standard across multinational medical device companies reporting regional segment assets.
zbh_segment_emea_goodwill_gross| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.36B | $1.36B | $1.35B | $1.33B | $1.33B | $1.37B | $1.41B | $1.40B | $1.41B | $1.40B |
| QoQ Change | — | -0.3% | -0.1% | -2.0% | +0.0% | +3.3% | +3.2% | -0.7% | +0.1% | -0.2% |
| YoY Change | — | — | — | -2.0% | +0.0% | +3.3% | — | — | +2.5% | — |